retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock 2: Weight Loss and Key Trial Findings – Bolt Pharmacy Retatrutide Delivers Significant Hemoglobin A1C

This plan starts with a loading phase and then moves to maintenance therapy

A systematic review conducted by the scientists at Staten Island University Hospital, US, describes the utility of glucagon-like peptide-1 receptor agonists in reducing binge eating behaviors in individuals with binge eating disorder and bulimia nervosa

I expected patients using these medications adjunctively with insulin to have potentially more hospitalizations and clinical visits from adverse GI events

During the UKPDS, there was a 16% reduction in CVD events (combined fatal or nonfatal MI and sudden death) in the intensive glycemic control arm that did not reach statistical significance ( P = 0.052), and there was no suggestion of benefit on other CVD outcomes (e.g., stroke)

Long-term success depends on consistent medication use and maintaining healthy lifestyle habits